Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Pågående studier och artiklar

The current studies and articles in writing, lead by COVID Symptom Study Sweden group, are listed below

White Paper

Aims:

1. Describe the cohort and compare with Sweden in general.
2. Describe the prediction model.
3. Compare model output with hospital and test data.
4. Use NOVUS data to provide an epi-curve for the entire epidemic.

Diabetes as a risk factor for COVID-19 severity and disease duration

Aim: Investigate the direct effects of type 1 and 2 diabetes, on COVID-19.

Exposures: Type 1 and 2 diabetes.

Outcomes: C-19 disease severity (hospitalization, need of respiratory support) and C-19 duration.

Optimizing prediction of COVID-19 in diabetes and obesity

Aim: To investigate if the coalescence of specific COVID-19 symptoms differs depending on diabetes and degree of obesity (defined using BMI).
Subjects: mainly PCR + participants.

2021-03-14